JULIE CEASAR: Open Payments
NPI 1861680274 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,973 in 155 payments from 16 companies in 2025. Trend: 2023 $3,146 · 2024 $2,921 · 2025 $2,973
Food & beverage: $2,772Education: $201
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $393 |
| Otsuka America Pharmaceutical, Inc. | 17 | $378 |
| Teva Pharmaceuticals USA, Inc. | 16 | $338 |
| Axsome Therapeutics, Inc. | 14 | $308 |
| Janssen Pharmaceuticals, Inc | 13 | $233 |
| Vanda Pharmaceuticals Inc. | 13 | $192 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $186 |
| Alkermes, Inc. | 8 | $180 |
| Lundbeck LLC | 8 | $169 |
| Supernus Pharmaceuticals, Inc. | 4 | $139 |
Products named: REXULTI, VRAYLAR, Auvelity, SPRAVATO, FANAPT, CAPLYTA, ARISTADA, Qelbree.
Industry payments across LA — which companies pay providers there.
